GlassScriptPhysician profile
Paul J Talbot
NPI 1912095100
$1,916.27
in general payments reported to CMS, 2019-2025
18 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $244 · 2021: $228 · 2022: $223 · 2023: $356 · 2024: $363 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $664.40 | 2019-2022 | |
| Abbvie INC. | $421.09 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Kerecis Limited | $175.15 | 2020-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Galderma Laboratories, L.P. | $175.04 | 2019-2025 | Dysport |
| Revance Therapeutics, INC. | $143.99 | 2024-2025 | Daxxify |
| Integra Lifesciences Corporation | $64.67 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $39.19 | 2023 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Organogenesis INC. | $33.61 | 2024 | Puraply Am |
| Tela Bio, INC. | $27.82 | 2024 | Ovitex 2s |
| Sanara Medtech INC. | $25.66 | 2021 | |
| Ge Healthcare | $22.92 | 2024 | |
| Mimedx Group, INC. | $22.03 | 2025 | |
| Motiva USA, LLC | $21.79 | 2025 | |
| Lifenet Health | $20.78 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $16.10 | 2023 | Exparel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.02 | 2020 | |
| Incyte Corporation | $14.91 | 2022 | |
| Acera Surgical, INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Talbot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.